Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 363

1.

Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen.

Freedland SJ, Sutter ME, Dorey F, Aronson WJ.

Urology. 2003 Feb;61(2):365-9.

PMID:
12597949
2.

Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.

Freedland SJ, Jalkut M, Dorey F, Sutter ME, Aronson WJ.

Urology. 2000 Jul;56(1):87-91.

PMID:
10869631
3.

Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database.

Freedland SJ, Aronson WJ, Csathy GS, Kane CJ, Amling CL, Presti JC Jr, Dorey F, Terris MK; SEARCH Database Study Group.

Urology. 2003 Apr;61(4):742-7.

PMID:
12670558
4.
5.

Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer.

Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR.

J Urol. 2003 Jan;169(1):157-63.

PMID:
12478126
6.
7.

Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.

Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24.

PMID:
15708249
8.

Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8.

Manoharan M, Bird VG, Kim SS, Civantos F, Soloway MS.

BJU Int. 2003 Oct;92(6):539-44.

9.

Predicting biochemical recurrence after radical prostatectomy for patients with organ-confined disease using p27 expression.

Freedland SJ, de Gregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Elashoff DA, Reiter RE, Aronson WJ.

Urology. 2003 Jun;61(6):1187-92.

PMID:
12809895
10.

Substratification of stage T1C prostate cancer based on the probability of biochemical recurrence.

Gretzer MB, Epstein JI, Pound CR, Walsh PC, Partin AW.

Urology. 2002 Dec;60(6):1034-9.

PMID:
12475665
11.
12.

Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE.

Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS, Carroll PR.

Urology. 2002 Apr;59(4):560-5.

PMID:
11927314
13.

The relationship between age at time of surgery and risk of biochemical failure after radical prostatectomy.

Barlow LJ, Badalato GM, Bashir T, Benson MC, McKiernan JM.

BJU Int. 2010 Jun;105(12):1646-9. doi: 10.1111/j.1464-410X.2009.08977.x. Epub 2009 Oct 26.

15.

Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.

Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC Jr; SEARCH Database Study Group.

J Urol. 2003 Jun;169(6):2136-41.

PMID:
12771735
16.

Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database.

Freedland SJ, Presti JC Jr, Amling CL, Kane CJ, Aronson WJ, Dorey F, Terris MK; SEARCH Database Study Group.

Urology. 2003 Apr;61(4):736-41.

PMID:
12670557
19.
20.

Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

Freedland SJ, Amling CL, Dorey F, Kane CJ, Presti JC Jr, Terris MK, Aronson WJ; Shared Equal Access Regional Cancer Hospital Database Study Group.

Urology. 2002 Oct;60(4):670-4.

PMID:
12385931

Supplemental Content

Support Center